BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pacheco T, Monteiro S, Barros L, Silva J. Perianal disease in inflammatory bowel disease: Broadening treatment and surveillance strategies for anal cancer. World J Gastroenterol 2024; 30(28): 3373-3385 [PMID: 39091713 DOI: 10.3748/wjg.v30.i28.3373]
URL: https://www.wjgnet.com/1007-9327/full/v30/i28/3373.htm
Number Citing Articles
1
Akhilesh Swaminathan, Miles P Sparrow. Perianal Crohn’s disease: Still more questions than answersWorld Journal of Gastroenterology 2024; 30(39): 4260-4266 doi: 10.3748/wjg.v30.i39.4260
2
Hajime Kayano, Ken-Ichi Okada, Seiichiro Yamamoto, Kazuo Koyanagi. Establishment of a surveillance program for anal cancer in Crohn's diseaseWorld Journal of Gastroenterology 2024; 30(45): 4844-4849 doi: 10.3748/wjg.v30.i45.4844
3
Jai P Singh, Maryam Aleissa, Ernesto R Drelichman, Vijay K Mittal, Jasneet S Bhullar. Navigating the complexities of perianal Crohn’s disease: Diagnostic strategies, treatment approaches, and future perspectivesWorld Journal of Gastroenterology 2024; 30(44): 4745-4753 doi: 10.3748/wjg.v30.i44.4745
4
Yanlan Wu, Hao Ge, Haoran Zhao, Kaiping Zou, Pei Wang, Yi Wang, Yang Zhang. The active ingredient β-sitosterol in the anti-inflammatory agents alleviates perianal inflammation in rats by inhibiting the expression of Srebf2, activating the PPAR signaling pathway, and altering the composition of gut microbiotaInternational Immunopharmacology 2025; 152: 114470 doi: 10.1016/j.intimp.2025.114470
5
Payal Bhatnagar, Sherreen Elhariri, Ismail A S Burud, Nabil Eid. Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapyWorld Journal of Gastroenterology 2025; 31(9): 100221 doi: 10.3748/wjg.v31.i9.100221